Physician

Barbara A Pisani, MD

According to 2025 Medicare claims, Barbara Pisani, MD (NPI: 1366493751) practices advanced heart failure and transplant cardiology in the Winston-Salem, NC market, with the plurality of this provider's patient population coming from Forsyth, NC. This provider's primary affiliated billing organization is WAKE FOREST UNIVERSITY HEALTH SCIENCES (NPI: 1003803032; TIN: 223849199) and primary practice location at 27157-0001. Pisani is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), participating under the MSSP model.

Pisani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 89 traditional Medicare patients, billed 509 HCPCS/CPT codes, and received $38,632 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,050 prescription claims across 246 beneficiaries totaling $1,370,411 in drug costs, led by Vyndamax (Tafamidis). DME data shows 550 claims. Open Payments data shows 9 records totaling $1,824. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $73,767 to $38,632. In contrast, Part D prescription costs have moved sharply higher in recent years, from $71,080 to $1,370,411. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $9,536 and ending at $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	130	940	$73,767
2016	124	404	$33,883
2017	148	676	$52,391
2018	155	600	$51,064
2019	148	663	$52,451
2020	128	535	$47,556
2021	122	454	$40,414
2022	124	409	$36,657
2023	106	452	$33,409
2024	89	509	$38,632

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	139	1,814	$71,080
2016	155	1,337	$84,632
2017	178	1,289	$64,491
2018	175	1,434	$88,984
2019	165	1,124	$81,805
2020	173	1,194	$93,318
2021	173	1,090	$82,109
2022	239	1,559	$271,166
2023	275	2,285	$637,792
2024	246	2,050	$1,370,411

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	94	621	$151,494
2016	67	462	$23,158
2017	49	235	$10,666
2018	49	617	$39,187
2019	65	373	$16,343
2020	56	342	$12,165
2021	35	144	$3,950
2022	39	273	$5,678
2023	28	291	$6,542
2024	52	550	$8,451

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	53	133	$96
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	18	44	$56
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	14	63	$36
93750	Evaluation of lower heart chamber assist device	14	94	$28
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	15	22	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	41	1,230	$953,810
Entresto	Sacubitril/Valsartan	99	5,313	$118,374
Jardiance	Empagliflozin	45	2,730	$48,648
Eliquis	Apixaban	46	1,920	$36,785
Repatha Sureclick	Evolocumab	12	728	$14,030

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	18	127	$2,277
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	18	158	$2,195
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	89	$1,636
J7507	Tacrolimus, immediate release, oral, 1 mg	N	16	113	$1,509
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	20	$815

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$322	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$1,502	ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Barbara A. Pisani, MD?

Tedicare shows public-source Medicare data for Barbara A. Pisani, MD (NPI 1366493751), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Barbara A. Pisani, MD have ACO affiliation data?

Barbara A. Pisani, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033).

What billing organization is linked to Barbara A. Pisani, MD?

Barbara A. Pisani, MD is linked to WAKE FOREST UNIVERSITY HEALTH SCIENCES (billing NPI 1003803032) in the available physician profile data.

Does Barbara A. Pisani, MD have Open Payments data?

Barbara A. Pisani, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.